Publications by authors named "Steven M Devine"

100Publications

Transplantation of Allogeneic Cryopreserved Hematopoietic Cell Grafts during the COVID-19 Pandemic: a National Marrow Donor Program Perspective.

Authors:
Steven M Devine

Am J Hematol 2020 Nov 18. Epub 2020 Nov 18.

National Marrow Donor Program, Minneapolis, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.26052DOI Listing
November 2020

Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia.

Biol Blood Marrow Transplant 2020 07 8;26(7):e161-e166. Epub 2020 May 8.

Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Hematology-Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.04.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206419PMC
July 2020

Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.

Biol Blood Marrow Transplant 2020 07 10;26(7):1312-1317. Epub 2020 Apr 10.

Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; BMT and Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194895PMC
July 2020

Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2019 10 20;25(10):1993-2001. Epub 2019 Jun 20.

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.06.014DOI Listing
October 2019

Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience.

Leuk Lymphoma 2019 09 15;60(9):2223-2229. Epub 2019 Feb 15.

Department of Pharmacy, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , 43210 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1573996DOI Listing
September 2019

A challenge to discriminating psychosocial eligibility criteria: exploring the ethical justification for excluding patients with psychosocial risk factors from hematopoietic cell transplantation.

Bone Marrow Transplant 2018 11 6;53(11):1474-1477. Epub 2018 Jun 6.

Center for Bioethics and Medical Humanities, and Department of Palliative Care, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-018-0213-6
Publisher Site
http://dx.doi.org/10.1038/s41409-018-0213-6DOI Listing
November 2018

Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide: Does Graft Source Matter?

Authors:
Steven M Devine

J Clin Oncol 2017 09 10;35(26):2984-2986. Epub 2017 Jul 10.

Steven M. Devine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.73.7775
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.73.7775DOI Listing
September 2017

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

J Clin Oncol 2017 Apr 13;35(11):1154-1161. Epub 2017 Feb 13.

Bart L. Scott and H. Joachim Deeg, Fred Hutchinson Cancer Research Center, Seattle, WA; Marcelo C. Pasquini, Brent R. Logan, Mehdi Hamadani, and Mary M. Horowitz, Medical College of Wisconsin, Milwaukee, WI; Juan Wu and Adam M. Mendizabal, Emmes Corporation, Rockville, MD; Steven M. Devine, Ohio State University Comprehensive Cancer Center, Columbus, OH; David L. Porter, University of Pennsylvania, Philadelphia, PA; Richard T. Maziarz, Oregon Health and Science University, Portland, OR; Erica D. Warlick, University of Minnesota, Minneapolis; Jennifer Le-Rademacher, Mayo Clinic, Rochester, MN; Hugo F. Fernandez, Moffitt Cancer Center, Tampa, FL; Edwin P. Alyea, Dana Farber Cancer Institute, Boston, MA; Asad Bashey, Northside Hospital Cancer Institute, Atlanta, GA; Sergio Giralt, Memorial Sloan Kettering Cancer Center, New York, NY; Nancy L. Geller and Eric Leifer, National Heart, Lung, and Blood Institute, Bethesda, MD; and Mitchell E. Horwitz, Duke University, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.7091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455603PMC
April 2017

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.

Neurology 2017 Feb 1;88(9):842-852. Epub 2017 Feb 1.

From the Colorado Blood Cancer Institute (R.A.N.), Denver; Baylor College of Medicine (G.J.H.), Houston, TX; Ohio State University (M.K.R., S.M.D.), Columbus; MD Anderson Cancer Research Center (U.P.), Houston, TX; Rho, Inc. (K.C.S.), Chapel Hill, NC; National Institute of Allergy and Infectious Diseases (L.M.G.), National Institutes of Health, Bethesda, MD; Division of Brain Sciences (P.A.M.), Imperial College London, UK; City of Hope National Medical Center (H.O.), Duarte, CA; Immune Tolerance Network (P.H.S.), University of California San Francisco; University of Texas Southwestern (O.S.), Dallas; NeuroRx (D.L.A.), McGill University, Montreal, Canada; Fred Hutchinson Cancer Research Center (G.E.G.), University of Washington (M.H.W., A.W., G.H.K.); and Swedish Hospital Medical Center (J.D.B.), Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331868PMC
February 2017

How do stem cells mobilize? Bridging the GAP.

Authors:
Steven M Devine

Blood 2016 09;128(11):1445-6

THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2016-07-72
Publisher Site
http://dx.doi.org/10.1182/blood-2016-07-726414DOI Listing
September 2016

Practice Patterns and Preferences Among Hematopoietic Cell Transplantation Clinicians.

Biol Blood Marrow Transplant 2016 11 29;22(11):2092-2099. Epub 2016 Jul 29.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067220PMC
http://dx.doi.org/10.1016/j.bbmt.2016.07.014DOI Listing
November 2016

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.

J Clin Oncol 2015 Dec 2;33(35):4167-75. Epub 2015 Nov 2.

Steven M. Devine and William Blum, Ohio State University, Columbus, OH; Kouros Owzar, Flora Mulkey, Vera Hars, and Alexander B. Sibley, Alliance Statistics and Data Center, Duke University, Durham; Thomas C. Shea, University of North Carolina, Chapel Hill, NC; Richard M. Stone, Robert J. Soiffer, and Edwin P. Alyea, Dana-Farber Cancer Institute; Yi-Bin Chen, Massachusetts General Hospital, Boston, MA; Jack W. Hsu, University of Florida, Gainesville, FL; Richard E. Champlin, MD Anderson Cancer Research Center, Houston, TX; Ravi Vij, Washington University, St. Louis, MO; James Slack, Mayo Clinic, Scottsdale, AZ; Richard A. Larson, University of Chicago, Chicago, IL; Sergio Giralt, Memorial Sloan Kettering Cancer Center, New York, NY; Shelly Carter, The EMMES Corporation, Bethesda, MD; Mary M. Horowitz, Medical College of Wisconsin, Milwaukee, WI; and Charles Linker, University of California at San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.7273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658453PMC
December 2015

Tocilizumab for steroid refractory acute graft-versus-host disease.

Leuk Lymphoma 2016 3;57(1):81-5. Epub 2015 Jul 3.

b Division of Hematology, Department of Internal Medicine , James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1045896DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698359PMC
October 2016

Improved accuracy of acute graft-versus-host disease staging among multiple centers.

Best Pract Res Clin Haematol 2014 Sep-Dec;27(3-4):283-7. Epub 2014 Oct 15.

Translational Research Center, The Tisch Cancer Institute, The Icahn School of Medicine at Mount Sinai Hospital, 1470 Madison Avenue, New York, NY 10029, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2014.10.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381784PMC
July 2015

Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity.

J Am Acad Dermatol 2014 Oct 1;71(4):745-53. Epub 2014 Jul 1.

Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.05.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165782PMC
October 2014

Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201.

J Clin Oncol 2014 Aug 30;32(22):2365-72. Epub 2014 Jun 30.

Edmund K. Waller and Wayne A.C. Harris, Emory University, Atlanta, GA; Brent R. Logan, Medical College of Wisconsin, Milwaukee, WI; Steven M. Devine, Ohio State University, Columbus, OH; David L. Porter, University of Pennsylvania, Philadelphia, PA; Shin Mineishi, University of Alabama at Birmingham, Birmingham, AL; John M. McCarty, Medical College of Virginia, Richmond, VA; Corina E. Gonzalez, Georgetown University Hospital, Washington, DC; Thomas R. Spitzer, Massachusetts General Hospital, Boston, MA; Oleg I. Krijanovski, Sutter East Bay Medical Foundation, Berkeley, CA; Michael L. Linenberger and Ann Woolfrey, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan Howard and Dennis L. Confer, National Marrow Donor Program, Minneapolis, MN; Juan Wu, EMMES Corporation, Rockville, MD; and Claudio Anasetti, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.4577DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180368PMC
August 2014

Genetic modification of T cells redirected toward CS1 enhances eradication of myeloma cells.

Clin Cancer Res 2014 Aug 27;20(15):3989-4000. Epub 2014 Mar 27.

Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119545PMC
August 2014

Graft-versus-host disease: why have we not made more progress?

Curr Opin Hematol 2014 Mar;21(2):141-7

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131840PMC
March 2014

Reprint of: Re-examining the role of high-dose chemotherapy in the treatment of light chain amyloidosis.

Authors:
Steven M Devine

Biol Blood Marrow Transplant 2014 Feb 12;20(2 Suppl):S2-S7. Epub 2014 Jan 12.

Blood and Marrow Transplant Program, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791140001
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2013.11.035DOI Listing
February 2014

FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcome.

Biol Blood Marrow Transplant 2014 Mar 21;20(3):309-13. Epub 2013 Dec 21.

Division of Hematology, Department of Internal Medicine, College of Medicine, Ohio State University, Columbus, Ohio; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; Blood and Marrow Transplantation Program, The James Cancer Hospital, Ohio State University, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.11.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943635PMC
March 2014

Re-examining the role of high-dose chemotherapy in the treatment of light chain amyloidosis.

Authors:
Steven M Devine

Biol Blood Marrow Transplant 2014 Jan 27;20(1):14-9. Epub 2013 Nov 27.

Blood and Marrow Transplant Program, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791130055
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2013.11.015DOI Listing
January 2014

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial.

J Clin Oncol 2013 Nov 14;31(33):4199-206. Epub 2013 Oct 14.

Philippe Armand and Edie Weller, Dana-Farber Cancer Institute; David E. Avigan, Beth Israel Deaconess Medical Center; Yi-Bin Chen, Massachusetts General Hospital, Boston, MA; Arnon Nagler, Chaim Sheba Medical Center, Tel-Hashomer; Reuven Or, Hadassah Medical Center, Jerusalem; Rinat Rotem-Yehudar, CureTech, Yavne, Israel; Steven M. Devine, The Ohio State University Comprehensive Cancer Center, Ohio State University, Columbus; Hillard M. Lazarus, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH; Mark S. Kaminski, University of Michigan, Ann Arbor, MI; H. Kent Holland, Northside Hospital; Edmund K. Waller, Winship Cancer Institute, Emory University, Atlanta, GA; Jane N. Winter and Leo I. Gordon, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine; Stephanie A. Gregory, Rush Medical Center, Chicago, IL; James R. Mason, Scripps Clinic; Edward D. Ball, Moores University of California at San Diego Cancer Center, University of California, San Diego; John M. Timmerman and David Andorsky, University of California, Los Angeles, Los Angeles, CA; Joseph W. Fay, Baylor Research Institute, Baylor University Medical Center, Dallas; Chitra M. Hosing, The University of Texas MD Anderson Cancer Center, Houston, TX; David A. Rizzieri, Duke Cancer Center, Durham, NC; Joseph P. Uberti, Karmanos Cancer Institute, Detroit, MI; Markus Y. Mapara, University of Pittsburgh School of Medicine and Cancer Institute, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2012.48.3685
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.48.3685DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878008PMC
November 2013

Chemotherapeutic agents increase the risk for pulmonary function test abnormalities in patients with multiple myeloma.

Clin Lymphoma Myeloma Leuk 2012 Oct 15;12(5):325-9. Epub 2012 Sep 15.

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, the Ohio State University Medical Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2012.06.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481157PMC
October 2012

Toward a more rational policy for autologous hematopoietic stem cell mobilization.

Authors:
Steven M Devine

Biol Blood Marrow Transplant 2012 Oct 11;18(10):1468-70. Epub 2012 Aug 11.

Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791120031
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2012.08.001DOI Listing
October 2012

Pulmonary rehabilitation for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2012 Aug 30;18(8):1250-4. Epub 2012 Jan 30.

Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University Medical Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.01.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378799PMC
August 2012

Can we build a better allograft?

Authors:
Steven M Devine

Blood 2011 Dec;118(25):6478-9

The Ohio State University Comprehensive Cancer Center.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2011-10-38
Publisher Site
http://dx.doi.org/10.1182/blood-2011-10-386524DOI Listing
December 2011

Hematopoietic stem cell transplantation for cutaneous T-cell lymphoma.

Authors:
Steven M Devine

Clin Lymphoma Myeloma Leuk 2010 Sep;10 Suppl 2:S96-8

The Ohio State University Comprehensive Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLML.2010.s.018DOI Listing
September 2010

Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias.

Haematologica 2010 Jul 11;95(7):1098-105. Epub 2010 May 11.

Division of Hematology and Oncology and the Comprehensive Cancer Center, Department of Medicine, The Ohio State University, B310 Starling-Loving Hall, 320 West 10 Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2009.017103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895033PMC
July 2010

Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas.

Biol Blood Marrow Transplant 2009 May 9;15(5):547-53. Epub 2009 Mar 9.

Hematology and Oncology, Arthur G James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.01.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953134PMC
May 2009

Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma.

Leuk Lymphoma 2009 Mar;50(3):349-56

Division of Hematology-Oncology, Department of Internal Medicine, Arthur G James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190902730227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695225PMC
March 2009

Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.

Leuk Lymphoma 2008 Oct;49(10):1893-8

Department of Hematology and Oncology and Bone Marrow Transplantation, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/1042819080227090
Publisher Site
http://dx.doi.org/10.1080/10428190802270902DOI Listing
October 2008

High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.

Eur J Haematol 2008 Dec 4;81(6):425-31. Epub 2008 Sep 4.

Department of Internal Medicine, Division of Hematology-Oncology, Arthur G James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2008.01146.xDOI Listing
December 2008

Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma.

Biol Blood Marrow Transplant 2008 Jul;14(7):840-6

Washington University School of Medicine, St. Louis, Missouri 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2008.05.002DOI Listing
July 2008